These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 5741831)

  • 61. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
    Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
    Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FAILURE OF RESERPINE TO DEPLETE NORADRENALINE NEURONS OF ALPHA-METHYLNORADRENALINE FORMED FROM ALPHA-METHYL DOPA.
    CARLSSON A; DAHLSTROEM A; FUXE K; HILLARP NA
    Acta Pharmacol Toxicol (Copenh); 1965; 22():270-6. PubMed ID: 14328199
    [No Abstract]   [Full Text] [Related]  

  • 63. Isolated catecholaminergic projections from substantia nigra and locus coeruleus to caudate, hippocampus and cerebral cortex formed by intraocular sequential double brain grafts.
    Olson L; Seiger A; Hoffer B; Taylor D
    Exp Brain Res; 1979 Mar; 35(1):47-67. PubMed ID: 436990
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 65. The postnatal ontogeny of monoamine-containing neurones in the central nervous system of the albino rat.
    Loizou LA
    Brain Res; 1972 May; 40(2):395-418. PubMed ID: 4537284
    [No Abstract]   [Full Text] [Related]  

  • 66. Brain catecholamines and the reserpine-induced stimulation of the pituitary-adrenal system.
    Hirsch GH; Moore KE
    Neuroendocrinology; 1968; 3(6):398-405. PubMed ID: 4388076
    [No Abstract]   [Full Text] [Related]  

  • 67. Studies on the uptake and accumulation of 3H-noradrenaline in adenergic nerves after pretreatment with reserpine, nialamide and a tyrosine-hydroxylase inhibitor.
    Hamberger B; Jonsson G; Almfors T; Sachs C
    Br J Pharmacol; 1968 Sep; 34(1):225P-226P. PubMed ID: 5676027
    [No Abstract]   [Full Text] [Related]  

  • 68. Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis.
    Fuxe K; Goldstein M; Hökfelt T; Jonsson G; Lidbrink P
    Adv Neurol; 1974; 5():405-19. PubMed ID: 4374065
    [No Abstract]   [Full Text] [Related]  

  • 69. [Luminescent-histochemical study of the effect of atropine and dimethoxydichlorvinylphosphate on catecholamine concentration in certain rat brain structures].
    Kutsenko SA; Savateev NV
    Biull Eksp Biol Med; 1981 Jun; 91(6):702-3. PubMed ID: 7272489
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Biochemistry of the extrapyramidal system--from anatomical viewpoint].
    Sano Y; Murase Y
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):859-68. PubMed ID: 4898006
    [No Abstract]   [Full Text] [Related]  

  • 71. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 72. UPTAKE OF L-DOPA AND NORADRENALINE BY CENTRAL CATECHOLAMINE NEURONS.
    FUXE K; HILLARP NA
    Life Sci (1962); 1964 Dec; 3():1403-6. PubMed ID: 14248629
    [No Abstract]   [Full Text] [Related]  

  • 73. Monoaminergic-cholinergic relationships and the chemical communication matrix of the substantia nigra and neostriatum.
    Butcher LL; Woolf NJ
    Brain Res Bull; 1982; 9(1-6):475-92. PubMed ID: 7172036
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Histochemical studies on the release of the adrenergic transmitter by nerve impulses in combination with drugs, especially adrenergic neuron blocking agents.
    Malmfors T
    Pharmacology; 1969; 2(3):138-50. PubMed ID: 4310294
    [No Abstract]   [Full Text] [Related]  

  • 75. Histochemical studies on the effect of nerve impulses on exogenous catecholamines taken up into the adrenergic nerves of reserpine-pretreated animals.
    Malmfors T
    Pharmacology; 1969; 2(4):193-208. PubMed ID: 4308917
    [No Abstract]   [Full Text] [Related]  

  • 76. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat.
    van der Kooy D; Hattori T
    Brain Res; 1980 Mar; 186(1):1-7. PubMed ID: 7357440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
    Pfeifer AK; Galambos E
    Psychopharmacologia; 1967; 11(2):130-5. PubMed ID: 5588185
    [No Abstract]   [Full Text] [Related]  

  • 78. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 79. [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].
    Constantinidis J; Bartholini G; Geissbühler F; Tissot R
    Experientia; 1970 Apr; 26(4):381-3. PubMed ID: 5439606
    [No Abstract]   [Full Text] [Related]  

  • 80. Histofluorescence analysis of several systems of catecholaminergic nerve fibres within the rat neostriatum revealed by either restricted lesions of the substantia nigra or gamma-hydroxybutyrate.
    Arluison M; Javoy-Agid F; Feuerstein C; Tauc M; Conrath-Verrier M; Mailly P
    Brain Res Bull; 1982; 9(1-6):355-65. PubMed ID: 7172034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.